title: Bridging anticoagulation for patients on long-term vitamin-K-antagonists. A prospective 1 year registry of 311 episodes.
authors.forename: K M
authors.initials: KM
authors.lastname: Halbritter
authors.forename: A
authors.initials: A
authors.lastname: Wawer
authors.forename: J
authors.initials: J
authors.lastname: Beyer
authors.forename: W
authors.initials: W
authors.lastname: Oettler
authors.forename: S M
authors.initials: SM
authors.lastname: Schellong
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012042:Registries; D013923:Thromboembolism / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D014812:Vitamin K / Q000037:antagonists & inhibitors*
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014812:Vitamin K